[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100304269":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":10,"locations":19,"responsibleParty":32,"collaborators":10,"id":34,"slug":35,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":10,"acronym":39,"eligibilityCriteria":40,"healthyVolunteers":36,"sex":41,"minAge":42,"maxAge":10,"enrollmentInfo":43,"targetDuration":10,"studyType":46,"phases":10,"briefSummary":47,"conditions":48,"keywords":50,"overallStatus":53,"whyStopped":10,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Besancon","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Quality of life questionnaires",null,"Data will be collected retrospectively and prospectively.",[13],"Other: Quality of life",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Quality of life","Dermatology Life Quality Index, Angioedema Quality of Life Questionnaire, Angioedema Activity Score",[9],[20],{"facility":21,"status":10,"city":22,"state":10,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":10},"CHU Besançon","Besançon","25000","France","FR",{"type":27,"coordinates":28},"Point",[29,30],6.01815,47.24878,{"lat":30,"lon":29},{"type":33,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100304269","study-of-clinical-biological-characteristics-and-quality-of-life-of-patients-with-hereditary-or-acquired-non-drug-induced-bradykinin-mediated-angioedema-monitored-in-besanons-partner-site-reference-center-for-studies-of-kinin-mediated-angioedema-creak-100304269",false,"NCT03240991","Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)","QUALANGIO","Inclusion Criteria:\n\n* Clinically documented angioedema due to C1 inhibitor deficiency, hereditary (type I et II) or acquired\n* Clinically documented angioedema with normal C1 inhibitor activity (hereditary type III)\n\nExclusion Criteria:\n\n* Acquired angioedema with normal C1 inhibitor activity (former \"drug-induced\")\n* Minor subjects\n* Vulnerable subjects (under guardianship\u002Fcuratorship\u002Ftutorship)\n* Pregnant women","ALL","18 Years",{"count":44,"type":45},45,"ACTUAL","OBSERVATIONAL","This study aims to describe quality of life in hereditary or acquired non drug-related bradykinin-mediated angioedema patients, using validated questionnaires",[49],"Angioedema",[51,52],"bradykinin-mediated angiodema","quality of life","COMPLETED","2018-04-13",{"date":56,"type":45},"2018-04-17",{"date":58,"type":45},"2016-07-11",{"date":60,"type":45},"2016-12-01",{"name":5,"class":6},1]